Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Romark Laboratories Logo
Romark Laboratories Growth Score
2
CB Rank
410825
Heat Score
8
Romark Laboratories discovers, develops and commercializes small molecules for treating infectious diseases and cancers.
Founded
obfuscation
PrivateVenture - Series Unknown Tampa, Florida, United States11-50 www.romark.com/
Biotechnology
Medical Device
Pharmaceutical
Overview

Romark Laboratories
Total Funding
obfuscation
Growth Score
2
Heat Score
8

Total Funding
obfuscation
obfuscation
Venture - Series Unknown raised
obfuscation
Growth Score2
-6 pts
in past quarter
Heat Score 8
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Romark Laboratories

CB Rank
410825
Romark Laboratories discovers, develops and commercializes small molecules for treating infectious diseases and cancers.
Founded
obfuscation
PrivateVenture - Series Unknown Tampa, Florida, United States11-50 www.romark.com/
Biotechnology
Medical Device
Pharmaceutical

Funding Rounds

Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Romark, L.C.
Also Known As Romark Laboratories, L.C.
Operating Status Active
Company Type For Profit
Founders  Jean-François Rossignol, Marc Ayers
About the Company
Romark Laboratories is a pharmaceutical company committed to the discovery, development and commercialization of innovative small molecules for treating infectious diseases and cancers
Phone Number +1 813 282 1162
Contact Email info@romark.com
Predictions & Insights

Products & Services

NT-300 (Nitazoxanide Extended-Release Tablets)
An investigational oral antiviral drug for treating and preventing acute respiratory illnesses caused by various respiratory viruses, including COVID-19.
Host-Directed Antiviral Therapeutics for Infectious Diseases
Small molecule drugs targeting host cellular pathways to treat infectious diseases by inhibiting viral replication and modulating immune response.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown
obfuscation
Venture Round - Romark Laboratories Logo
Venture Round - Romark Laboratories
—
obfuscation
— Venture - Series Unknown

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 55

Employee Profiles

News

News and Press

News•Dec 26, 2007
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$2.3MThis year, Romark Laboratories is projected to spend $2.3M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Pipeline reviews Logo
Pipeline reviews
96
Employee Screening Logo
Employee Screening
88
Data Exchanges Logo
Data Exchanges
84

Active Website Tech Count

19Romark Laboratories is actively using 19 technologies for its website, according to BuiltWith. These include HSTS, Content Delivery Network, and  Mobile Non Scaleable Content.

Total IP

41The intellectual property of Romark Laboratories includes 34 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Romark Laboratories has registered 7 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Romark Laboratories's headquarters? Romark Laboratories is located in Tampa, Florida, United States.When was the last funding round for Romark Laboratories? Romark Laboratories closed its last funding round on
obfuscation
from a Venture - Series Unknown round.Who are Romark Laboratories's competitors? Alternatives and possible competitors to Romark Laboratories may include Gilead Sciences, Vir Biotechnology, and  Arrowhead Pharmaceuticals.How much funding has Romark Laboratories raised to date? Romark Laboratories has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|